Diversatek Healthcare Expands Therapeutic Endoscopy Portfolio with Launch of EZ-Ject Injection Needle
Published: 23 Jan 2026
Author: Precedence Research
Diversatek Healthcare, a well-known developer of gastrointestinal (GI) devices and diagnostic test solutions, has announced the consumer introduction of its EZ-Jecttm Injection Needle. This is a new generation device that aims to advance the accuracy, safety, and effectiveness of therapeutic endoscopy procedures. EZ-Ject is an innovative, clinician-driven product that aligns with Diversatek's vision to ensure continual growth and expansion of its therapeutic accessory line.
The EZ-Ject Injection Needle has been designed with the direct input of endoscopy professionals in mind. They help it overcome some of the long-term usability issues encountered when using the device during GI procedures. The main characteristic of the device is a one-step locking system that holds the needle firmly in place without twisting it, making the procedure complex and saving precious time. Diversatek has a goal of facilitating consistent results by emphasizing ergonomic handling and reliable service in various clinical environments.
The introduction of EZ-Ject would also enhance the overall hemostasis products of Diversatek Healthcare. The device allows lift-assisted polypectomy and may be used as a monotherapy injection needle. This compatibility enables clinicians to provide treatment with patient-specific requirements without leaving the ecosystem of a single trusted device. Such integrated solutions are becoming more significant, as GI procedures keep becoming less invasive and more efficiency-oriented.
The EZ-Ject Injection Needle is indicative of Diversatek continuously working to convert clinician feedback into device innovation practice. The company is dividing the apparently minor yet essential details of device manipulation, including locking cranks and ergonomic control. This ensures less variability in processes and assures the application of safer and more predictable results. Furthermore, the emergence of EZ-Ject will come when there is an increasing demand for advanced therapeutic endoscopy equipment around the world.
Executive Statement
Stuart Tallmadge, Vice President at Diversatek Healthcare, emphasized the clinical motivation behind the product, stating, “At Diversatek Healthcare, we continuously look for ways to help clinicians perform GI procedures more safely and efficiently. The EZ-Ject Injection Needle was developed in direct response to ongoing customer feedback, with a strong focus on safety, usability, and reliability, key elements in delivering exceptional patient care.”